The PRINTO criteria for clinically inactive disease in juvenile dermatomyositis
- 26 June 2012
- journal article
- research article
- Published by BMJ in Annals Of The Rheumatic Diseases
- Vol. 72 (5), 686-693
- https://doi.org/10.1136/annrheumdis-2012-201483
Abstract
Objectives To develop data-driven criteria for clinically inactive disease on and off therapy for juvenile dermatomyositis (JDM). Methods The Paediatric Rheumatology International Trials Organisation (PRINTO) database contains 275 patients with active JDM evaluated prospectively up to 24 months. Thirty-eight patients off therapy at 24 months were defined as clinically inactive and included in the reference group. These were compared with a random sample of 76 patients who had active disease at study baseline. Individual measures of muscle strength/endurance, muscle enzymes, physician's and parent's global disease activity/damage evaluations, inactive disease criteria derived from the literature and other ad hoc criteria were evaluated for sensitivity, specificity and Cohen's κ agreement. Results The individual measures that best characterised inactive disease (sensitivity and specificity >0.8 and Cohen's κ >0.8) were manual muscle testing (MMT) ≥78, physician global assessment of muscle activity=0, physician global assessment of overall disease activity (PhyGloVAS) ≤0.2, Childhood Myositis Assessment Scale (CMAS) ≥48, Disease Activity Score ≤3 and Myositis Disease Activity Assessment Visual Analogue Scale ≤0.2. The best combination of variables to classify a patient as being in a state of inactive disease on or off therapy is at least three of four of the following criteria: creatine kinase ≤150, CMAS ≥48, MMT ≥78 and PhyGloVAS ≤0.2. After 24 months, 30/31 patients (96.8%) were inactive off therapy and 69/145 (47.6%) were inactive on therapy. Conclusion PRINTO established data-driven criteria with clearly evidence-based cut-off values to identify JDM patients with clinically inactive disease. These criteria can be used in clinical trials, in research and in clinical practice.Keywords
This publication has 47 references indexed in Scilit:
- The Paediatric Rheumatology International Trials Organisation provisional criteria for the evaluation of response to therapy in juvenile dermatomyositisArthritis Care & Research, 2010
- Long‐term muscular outcome and predisposing and prognostic factors in juvenile dermatomyositis: A case–control studyArthritis Care & Research, 2010
- Evaluation of 21-Numbered Circle and 10-Centimeter Horizontal Line Visual Analog Scales for Physician and Parent Subjective Ratings in Juvenile Idiopathic ArthritisThe Journal of Rheumatology, 2010
- Validation of manual muscle testing and a subset of eight muscles for adult and juvenile idiopathic inflammatory myopathiesArthritis Care & Research, 2010
- Effect of early treatment in polymyositis and dermatomyositisNeurology India, 2010
- Damage extent and predictors in adult and juvenile dermatomyositis and polymyositis as determined with the myositis damage indexArthritis & Rheumatism, 2009
- Clinical Characteristics and Outcomes of Juvenile and Adult DermatomyositisJournal of Korean Medical Science, 2009
- Normal scores for nine maneuvers of the Childhood Myositis Assessment ScaleArthritis Care & Research, 2004
- Measurement of health status in children with juvenile rheumatoid arthritisArthritis & Rheumatism, 1994